Androgen class drugs
20 results
Androderm (testosterone)
(Testosterone)Allergan, Inc.
Usage: ANDRODERM is indicated for replacement therapy in adult males with testosterone deficiency due to primary hypogonadism or hypogonadotropic hypogonadism. It is not approved for age-related hypogonadism or use in males under 18 years old.
Androgel (testosterone)
(Testosterone)ASCEND Therapeutics U.S., LLC
Usage: AndroGel 1.62% is indicated for replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary injury). Its safety and efficacy in age-related hypogonadism and males under 18 have not been established.
Aveed (testosterone undecanoate)
(testosterone undecanoate)ENDO USA, Inc.
Usage: AVEED is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. It is essential for patients who need therapy, considering the benefits against risks like POME and anaphylaxis. Not approved for age-related hypogonadism or use in males under 18.
Azmiro (testosterone cypionate)
(TESTOSTERONE CYPIONATE)Azurity Pharmaceuticals, Inc.
Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.
Depo-testosterone (testosterone cypionate)
(testosterone cypionate)Pharmacia and Upjohn Company LLC
Usage: DEPO-Testosterone Injection is indicated for replacement therapy in men with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin deficiency). Its safety and efficacy for "age-related hypogonadism" have not been established.
Esterified estrogens and methyltestosterone (esterified estrogens and methyltestosterone)
(Esterified Estrogens and Methyltestosterone)Bryant Ranch Prepack
Usage: Esterified Estrogens and Methyltestosterone Full and Half-Strength Tablets are indicated for treating moderate to severe vasomotor symptoms associated with menopause in patients not improved by estrogens alone. They are not effective during pregnancy and may cause severe fetal harm.
Jatenzo (testosterone undecanoate)
(testosterone undecanoate)TOLMAR Inc.
Usage: JATENZO (testosterone undecanoate) is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. It is not established for age-related hypogonadism or use in males under 18 years old.
Kyzatrex (testosterone undecanoate)
(TESTOSTERONE UNDECANOATE)Marius Pharmaceuticals
Usage: KYZATREX™ is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). Safety and efficacy in males under 18 have not been established.
Methyltestosterone (methyltestosterone)
(METHYLTESTOSTERONE)Amneal Pharmaceuticals of New York LLC
Usage: Androgens are indicated for testosterone replacement therapy in males with primary and hypogonadotropic hypogonadism, and for stimulating puberty in selected cases. In females, they are used in treating advanced inoperable metastatic breast cancer post-menopause. Treatment decisions should involve expert judgment, especially in oncology.
Natesto (testosterone)
(testosterone)Acerus Pharmaceuticals Corporation
Usage: Natesto is indicated for replacement therapy in adult males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. Conditions include testicular failure and pituitary-hypothalamic injuries. Its safety and efficacy in age-related hypogonadism and males under 18 have not been established.